✕
Login
Register
Back to News
Anteris Technologies Global To Discontinue Development Contributions Under Agreement With v2vmedtech; Required To Pay $400,000 Break Fee To v2vmedtech; Expects No Material Adverse Effect From Agreement Termination
Benzinga Newsdesk
www.benzinga.com
Neutral 87.0%
Neg 0%
Neu 87%
Pos 0%
-SEC Filing
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment